Special Issue "Personalized Diagnosis and Treatment of Patients with Sepsis"
Deadline for manuscript submissions: closed (10 August 2021) | Viewed by 12399
Interests: sepsis; autoimmune diseases; vasculitis; ormond disease; personalized therapy
Special Issues, Collections and Topics in MDPI journals
Interests: differential gene expression; transcriptomics, proteomics and metabolomics in sepsis and organ failure; redox-sensitive transcription factors and cellular stress responses
Diagnostics and therapy of sepsis still represent the "Holy Grail" of 21st century medicine. The aim of this Special Issue is to provide information on the current and potential use of personalized medicine in sepsis. Sepsis is a multifactorial clinical syndrome with an extremely dynamic clinical course, and is very diverse with respect to clinical phenotype. Early diagnosis is of crucial importance for the final clinical outcome. Previous studies have not identified a biomarker with sufficient sensitivity and specificity for the diagnosis of sepsis. Identification of the infectious agents or the use of molecular biology, next-gene sequencing has not brought significant benefits for patients in terms of early diagnosis. Therefore, we are currently searching for biomarkers, through “omics” technologies with sufficient diagnostic specificity and sensitivity, that are able to predict the clinical course of the disease, and patient response to therapy. Current progress in the use of systems biology technologies brings us hope that by using big data from clinical trials, such biomarkers will be found.
Dr. Miroslav Průcha
Prof. Dr.Michael Bauer
Dr. Roman Zahorec
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- clinical phenotypes
- personalized therapy